Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial

Newsome, PN, Fox, R, King, AL et al. (19 more authors) (2018) Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial. The Lancet Gastroenterology & Hepatology, 3 (1). pp. 25-36. ISSN 2468-1253

Abstract

Metadata

Authors/Creators:
  • Newsome, PN
  • Fox, R
  • King, AL
  • Barton, D
  • Than, N-N
  • Moore, J
  • Corbett, C
  • Townsend, S
  • Thomas, J
  • Guo, K
  • Hull, D
  • Beard, HA
  • Thompson, J
  • Atkinson, A
  • Bienek, C
  • McGowan, N
  • Guha, N
  • Campbell, J
  • Hollyman, D
  • Stocken, D ORCID logo https://orcid.org/0000-0001-8031-1738
  • Yap, C
  • Forbes, SJ
Copyright, Publisher and Additional Information: © 2017 The Author(s). Published by Elsevier Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Dates:
  • Published (online): 7 November 2017
  • Published: January 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 20 Aug 2020 12:43
Last Modified: 25 Jun 2023 22:23
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/S2468-1253(17)30326-6

Export

Statistics